Prophylaxis of graft rejection

Transplant rejection occurs when transplanted tissue is rejected by the immune system, which destroys the transplanted tissue. Transplant rejection can be diminished by determining the molecular similarity between donor and recipient and by using immunosuppressant drugs after transplant. The prevention of this condition conducts to the higher success of the transplant procedure.

Showing the single result

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Belatacept 8028708	CD80 , CD86	Fusion protein	Nulojix®	25 mg/mL	–	5 mg	-80°C	2025.01	221,00 €	view product Max: 10 Min: 2 Step: 1